A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM).

Kleinberg, Lawrence; Ye, Xiaobu; Supko, Jeff; Stevens, Glenn H J; Shu, Hui-Kuo; Mikkelsen, Tom; Lieberman, Frank; Lesser, Glenn; Lee, Emerson; Grossman, Stuart

Kleinberg, Lawrence; Ye, Xiaobu; Supko, Jeff; Stevens, Glenn H J; Shu, Hui-Kuo; Mikkelsen, Tom; Lieberman, Frank; Lesser, Glenn; Lee, Emerson; Grossman, Stuart.

Afiliação

Kleinberg L; Johns Hopkins University.
Ye X; Johns Hopkins School of Medicine.
Supko J; Harvard medical School.
Stevens GHJ; Cleveland Clinic.
Shu HK; Emory University.
Mikkelsen T; Henry Ford Health.
Lieberman F; University of Pittsburgh School of Medicine.
Lesser G; Wake Forest School of Medicine.
Lee E; Johns Hopkins School of Medicine.
Grossman S; Johns Hopkins School of Medicine.

Res Sq ; 2023 Oct 24.

Article em En | MEDLINE | ID: mdl-37961385

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Sq Ano de publicação: 2023 Tipo de documento: Article